Well set ahead of key product launches
BMK is seeing the rewards from its focus on aquaculture and a tighter cost base; continuing operations delivered Q1 2021 revenue growth of 18% to £29m, vs Q1 2020. When coupled with cost containment this provided an impressive 7.5x increase in EBITDA. This places BMK in a strong position to execute the next phase of the strategic drive to profitability through product launches and growth initiatives. Visibility is improving in Advanced Nutrition, along with early signs of recovery in some shrimp markets, solid performance in Genetics and a reduced loss in the newly restructured Health division. BMK’s prospects are improving along with momentum from new product launches. We upgrade our FY2021-23 forecasts leading to a net profit of £15.4m in FY 2023.The Group is seeing strategic focus pay off. With encouraging signs of recovery, BMK can leverage its central position in global aquaculture markets to support the launch of innovative products. As such, we increase our share price value to 88p per share from 72p. Grant of BMK08 + CleanTreat®️ Marketing Authorisation will provide further rerating potential.
Benchmark Holdings is principally engaged in the provision of technical services, products and knowledge that support the development of sustainable food and farming industries. Co.'s reportable segments include: Animal Health Division, which provides veterinary services, environmental services diagnostics and animal health products to aquaculture, and manufactures licenced veterinary vaccines and vaccine components; Genetics Division, which harnesses salmon breeding technologies combined with production facilities to provide a range of high genetic merit ova; and Advanced Animal Nutrition, which manufactures and provides nutrition and health products to the aquaculture industry.
Equity Development enables companies to become better understood and supported by investors. Since our launch in 1996 we have consistently focused on helping our clients improve their communication and relationships with both existing and potential shareholders. Our clients have come from a wide variety of sectors and domiciles, are both private and quoted and range in size from micro-cap to $multi-billions. We offer free access to company research notes written by experienced analysts. These notes include detailed forecasts, financial models and a fair value. We host regular Private Investor Forums at which investors have the opportunity to hear company directors present, and to ask questions. These are free to attend. We broadcast live Webinars with company management that include active Q&A. We also make the recordings available online. We arrange face to face meetings between private investors and company management. We are active users of Twitter, commenting daily on company news, share price moves, Directors’ Dealings, Equity Development Research Notes & Events.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.